Corrigendum to “Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation” [Biomaterials 35/24 (2014) 6278–6286](S0142961214004463)(10.1016/j.biomaterials.2014.04.048);Sustained localized presentation of RNA interfering molecules from in situ forming hydrogels to guide stem cell osteogenic differentiation

Biomaterials

Volumn 35, Issue 24, 2014, Pages 6278-6286

  Nguyen, Minh K ^a   Jeon, Oju ^a   Krebs, Melissa D ^a,c   Schapira, Daniel ^a   Alsberg, Eben ^a,b  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Geology and Geological Engineering   (United States)

Author keywords

Biomaterials; Bone regeneration; Gene delivery; Mesenchymal stem cells; Tissue engineering

Indexed keywords

BIOMATERIALS; BONE; CELL CULTURE; GENE TRANSFER; HYDROGELS; POLYETHYLENE GLYCOLS; RNA; SCAFFOLDS (BIOLOGY); STEM CELLS; TISSUE; TISSUE ENGINEERING; TISSUE REGENERATION;

BONE REGENERATION; GENE DELIVERY; MESENCHYMAL STEM CELL; MULTIPLE APPLICATIONS; OSTEOGENIC DIFFERENTIATION; POLYMERIC SCAFFOLD; THREEDIMENSIONAL (3-D); TWO DIMENSIONAL (2 D);

CELL ENGINEERING;

BONE MORPHOGENETIC PROTEIN 2; CALCIUM; MACROGOL; MICRORNA 20A; NOGGIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLASMID DNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RUNX2; ALKALINE PHOSPHATASE; HYDROGEL;

ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE TISSUE; CELL DIFFERENTIATION; CELL FATE; CELL FUNCTION; CROSS LINKING; DEGRADATION KINETICS; DOWN REGULATION; GELATION; GENE DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; MOLECULAR WEIGHT; OSTEOBLAST; PHYSICAL PARAMETERS; POLYMERIZATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; STEM CELL; TISSUE ENGINEERING; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; FLOW KINETICS; KINETICS; MESENCHYMAL STROMA CELL; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS; TIME;

ALKALINE PHOSPHATASE; CALCIUM; CELL DIFFERENTIATION; HUMANS; HYDROGELS; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; RHEOLOGY; RNA INTERFERENCE; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 84901406341     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2017.02.008     Document Type: Erratum

References (53)

1. Chen S., Do J.T., Zhang Q., Yao S., Yan F., Peters E.C., et al. Self-renewal of embryonic stem cells by a small molecule. Proc Natl Acad Sci U S A 2006, 103:17266-17271.
2. Jaiswal R.K., Jaiswal N., Bruder S.P., Mbalaviele G., Marshak D.R., Pittenger M.F. Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. JBio Chem 2000, 275:9645-9652.
3. Kwong F., Richardson S., Evans C. Chordin knockdown enhances the osteogenic differentiation of human mesenchymal stem cells. Arthritis Res Ther 2008, 10:R65.
4. Tzeng S.Y., Hung B.P., Grayson W.L., Green J.J. Cystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation. Biomaterials 2012, 33:8142-8151.
5. Ramasubramanian A., Shiigi S., Lee G., Yang F. Non-viral delivery of inductive and suppressive genes to adipose-derived stem cells for osteogenic differentiation. Pharm Res 2011, 28:1328-1337.
6. Zimmerman L.B., De Jess-Escobar J.M., Harland R.M. The spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 1996, 86:599-606.
7. Aspenberg P., Jeppsson C., Economides A. The bone morphogenetic proteins antagonist noggin inhibits membranous ossification. JBone Min Res 2001, 16:497-500.
8. Devlin R.D., Du Z., Pereira R.C., Kimble R.B., Economides A.N., Jorgetti V., et al. Skeletal overexpression of noggin results in osteopenia and reduced bone formation. Endocrinology 2003, 144:1972-1978.
9. Wu X.B., Li Y., Schneider A., Yu W., Rajendren G., Iqbal J., et al. Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. JClin Invest 2003, 112:924-934.
10. Wan D.C., Pomerantz J.H., Brunet L.J., Kim J.-B., Chou Y.-F., Wu B.M., et al. Noggin suppression enhances invitro osteogenesis and accelerates invivo bone formation. JBiol Chem 2007, 282:26450-26459.
11. Eskildsen T., Taipaleenmäki H., Stenvang J., Abdallah B.M., Ditzel N., Nossent A.Y., et al. MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells invivo. Proc Natl Acad Sci U S A 2011, 108:6139-6144.
12. Zhang J.-F., Fu W.-M., He M.-L., Xie W.-D., Lv Q., Wan G., et al. MiRNA-20a promotes osteogenic differentiation of human mesenchymal stem cells by co-regulating BMP signaling. RNA Biol 2011, 8:829-838.
13. Geckil H., Xu F., Zhang X., Moon S., Demirci U. Engineering hydrogels as extracellular matrix mimics. Nanomedicine 2010, 5:469-484.
14. Krebs M.D., Alsberg E. Localized, targeted, and sustained siRNA delivery. Chem Eur J 2011, 17:3054-3062.
15. Krebs M.D., Jeon O., Alsberg E. Localized and sustained delivery of silencing RNA from macroscopic biopolymer hydrogels. JAm Chem Soc 2009, 131:9204-9206.
16. Cao H., Jiang X., Chai C., Chew S.Y. RNA interference by nanofiber-based siRNA delivery system. JControl Release 2010, 144:203-212.
17. Rujitanaroj P.-O., Wang Y.-C., Wang J., Chew S.Y. Nanofiber-mediated controlled release of siRNA complexes for long term gene-silencing applications. Biomaterials 2011, 32:5915-5923.
18. Chen M., Gao S., Dong M., Song J., Yang C., Howard K.A., et al. Chitosan/siRNA nanoparticles encapsulated in PLGA nanofibers for siRNA delivery. ACS Nano 2012, 6:4835-4844.
19. Nelson C.E., Gupta M.K., Adolph E.J., Shannon J.M., Guelcher S.A., Duvall C.L. Sustained local delivery of siRNA from an injectable scaffold. Biomaterials 2012, 33:1154-1161.
20. Han H.D., Mora E.M., Roh J.W., Nishimura M., Lee S.J., Stone R.L., et al. Chitosan hydrogel for localized gene silencing. Cancer Biol Ther 2011, 11:839-845.
21. Kim Y.-M., Park M.-R., Song S.-C. Injectable polyplex hydrogel for localized and long-term delivery of siRNA. ACS Nano 2012, 6:5757-5766.
22. Takahashi H., Wang Y., Grainger D.W. Device-based local delivery of siRNA against mammalian target of rapamycin (mTOR) in a murine subcutaneous implant model to inhibit fibrous encapsulation. JControl Release 2010, 147:400-407.
23. Manaka T., Suzuki A., Takayama K., Imai Y., Nakamura H., Takaoka K. Local delivery of siRNA using a biodegradable polymer application to enhance BMP-induced bone formation. Biomaterials 2011, 32:9642-9648.
24. Nguyen K., Dang P.N., Alsberg E. Functionalized, biodegradable hydrogels for control over sustained and localized siRNA delivery to incorporated and surrounding cells. Acta Biomater 2013, 9:4487-4495.
25. Jeon O., Powell C., Solorio L.D., Krebs M.D., Alsberg E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. JControl Release 2011, 154:258-266.
26. Nguyen M.K., Lee D.S. Injectable biodegradable hydrogels. Macromol Biosci 2010, 10:563-579.
27. Slaughter B.V., Khurshid S.S., Fisher O.Z., Khademhosseini A., Peppas N.A. Hydrogels in regenerative medicine. Adv Mater 2009, 21:3307-3329.
28. Bhakta G., Rai B., Lim Z.X.H., Hui J.H., Stein G.S., van Wijnen A.J., et al. Hyaluronic acid-based hydrogels functionalized with heparin that support controlled release of bioactive BMP-2. Biomaterials 2012, 33:6113-6122.
29. Kinard L., Chu C.-Y., Tabata Y., Kasper F.K., Mikos A. Bone morphogenetic protein-2 release from composite hydrogels of oligo(poly(ethylene glycol) fumarate) and gelatin. Pharm Res 2013, 30:2332-2343.
30. Vo T.N., Kasper F.K., Mikos A.G. Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev 2012, 64:1292-1309.
31. Krebs M.D., Salter E., Chen E., Sutter K.A., Alsberg E. Calcium phosphate-DNA nanoparticle gene delivery from alginate hydrogels induces invivo osteogenesis. JBiomed Mater Res Part A 2010, 92A:1131-1138.
32. Chew S.A., Kretlow J.D., Spicer P.P., Edwards A.W., Baggett L.S., Tabata Y., et al. Delivery of plasmid DNA encoding bone morphogenetic protein-2 with a biodegradable branched polycationic polymer in a critical-size rat cranial defect model. Tissue Eng Part A 2010, 17:751-763.
33. Huang Y.C., Simmons C., Kaigler D., Rice K.G., Mooney D.J. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 2005, 12:418-426.
34. Mehta M., Schmidt-Bleek K., Duda G.N., Mooney D.J. Biomaterial delivery of morphogens to mimic the natural healing cascade in bone. Adv Drug Deliv Rev 2012, 64:1257-1276.
35. Mairhofer J., Grabherr R. Rational vector design for efficient non-viral gene delivery: challenges facing the use of plasmid DNA. Mol Biotechnol 2008, 39:97-104.
36. Elsabahy M., Nazarali A., Foldvari M. Non-viral nucleic acid delivery: key challenges and future directions. Curr Drug Deliv 2011, 8:235-244.
37. Vanderhooft J.L., Mann B.K., Prestwich G.D. Synthesis and characterization of novel thiol-reactive poly(ethylene glycol) cross-linkers for extracellular-matrix-mimetic biomaterials. Biomacromolecules 2007, 8:2883-2889.
38. Haynesworth S.E., Goshima J., Goldberg V.M., Caplan A.I. Characterization of cells with osteogenic potential from human marrow. Bone 1992, 13:81-88.
39. Lennon D., Haynesworth S., Bruder S., Jaiswal N., Caplan A. Human and animal mesenchymal progenitor cells from bone marrow: identification of serum for optimal selection and proliferation. Vitro Cell Dev Biol Anim 1996, 32:602-611.
40. Nguyen M.K., Huynh C.T., Lee D.S. pH-sensitive and bioadhesive poly(β-amino ester)-poly(ethylene glycol)-poly(β-amino ester) triblock copolymer hydrogels with potential for drug delivery in oral mucosal surfaces. Polymer 2009, 50:5205-5210.
41. Sawhney A.S., Pathak C.P., Hubbell J.A. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly (alpha.-hydroxy acid) diacrylate macromers. Macromolecules 1993, 26:581-587.
42. Drury J.L., Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24:4337-4351.
43. Zustiak S.P., Leach J.B. Hydrolytically degradable poly(ethylene glycol) hydrogel scaffolds with tunable degradation and mechanical properties. Biomacromolecules 2010, 11:1348-1357.
44. Alsberg E., Kong H.J., Hirano Y., Smith M.K., Albeiruti A., Mooney D.J. Regulating bone formation via controlled scaffold degradation. JDent Res 2003, 82:903-908.
45. Garripelli V.K., Kim J.K., Namgung R., Kim W.J., Repka M.A., Jo S. Anovel thermosensitive polymer with pH-dependent degradation for drug delivery. Acta Biomater 2010, 6:477-485.
46. Jeon O., Bouhadir K.H., Mansour J.M., Alsberg E. Photocrosslinked alginate hydrogels with tunable biodegradation rates and mechanical properties. Biomaterials 2009, 30:2724-2734.
47. Kong H.J., Alsberg E., Kaigler D., Lee K.Y., Mooney D.J. Controlling degradation of hydrogels via the size of crosslinked junctions. Adv Mater 2004, 16:1917-1921.
48. Elbert D.L., Pratt A.B., Lutolf M.P., Halstenberg S., Hubbell J.A. Protein delivery from materials formed by self-selective conjugate addition reactions. JControl Release 2001, 76:11-25.
49. van de Wetering P., Metters A.T., Schoenmakers R.G., Hubbell J.A. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. JControl Release 2005, 102:619-627.
50. Gao K., Huang L. Nonviral methods for siRNA delivery. Mol Pharm 2008, 6:651-658.
51. Höbel S., Aigner A. Polyethylenimine (PEI)/siRNA-mediated gene knockdown invitro and invivo. RNA Interference 2010, 283-297. Humana Press. W.-P. Min, T. Ichim (Eds.).
52. Ibrahim A.F., Weirauch U., Thomas M., Grünweller A., Hartmann R.K., Aigner A. microRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011, 71:5214-5224.
53. Lin T.H., Yang R.S., Tang C.H., Lin C.P., Fu W.M. PPARgamma inhibits osteogenesis via the down-regulation of the expression of COX-2 and iNOS in rats. Bone 2007, 41:562-574.